8-K
filed May 6, 2026, 7:59 PM ET
ticker DLHC
CIK 0000785557
earnings
confidence high
sentiment negative
materiality 0.80
DLH Q2 FY2026 net loss of $2.5M on revenue down 34%; backlog falls to $442.4M
DLH Holdings Corp.
2026-Q2 EPS reported
-$0.27
revenue$128,158,000
- Revenue $59.3M, down 33.5% YoY; net loss $(2.5)M vs income $0.9M; diluted EPS $(0.17) vs $0.06.
- Adjusted EBITDA $5.3M (9.0% margin) vs $9.4M (10.5% margin); free cash flow $3.8M vs $14.5M.
- Debt reduced to $132.7M from $136.6M at Q1 end; backlog $442.4M, down 14% from Sep 2025.
- Awarded 2-year sole source extension for NIH clinical research support contract.
- Management says legacy contract conversions to small businesses expected to complete in Q3 FY2026.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
DLH Reports Fiscal 2026 Second Quarter Results ATLANTA, May. 6, 2026 – DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development, today announced financial results for its fiscal second quarter ended March 31, 2026.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Adjusted EBITDA of $5.3 million, or 9.0% of revenue, with the Company's cost scaling initiatives sustaining adjusted EBITDA margin on the current revenue volume
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Operating Financial Summary Three Months Ended March 31, $ million 2026 2025 % Change Revenue $59.3 $89.2 (33.5)% Income (loss) from operations $(0.1) $5.1 (102.0)% Adjusted Income from operations $1.0 $5.1 (80.4)% Net income (loss) $(2.5) $0.9 (377.8)% Diluted Earnings (Loss) Per Share $(0.17) $0.06 (383.3)%
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Adjusted EBITDA $5.3 $9.4 (43.6)%
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Free cash flow of $3.8 million, with cash generation expected to accelerate in the second half of fiscal 2026
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Debt was reduced to $132.7 million, from $136.6 million at the end of the first quarter, with greater reductions expected before the end of fiscal 2026
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.7
DLH Holdings Corp. reported financial results for Three Months Ended March 31, 2026.
- Period
- Three Months Ended March 31, 2026
- Result
- reported results
Exact text from the filing
Awarded a two-year sole source extension of our contract to provide clinical research support services to NIH.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.